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Ethnopharmacological relevance: Aleurites moluccana L. (Willd) Euforbiaceae is a native tree of Indonesia
and India that has become acclimatized and well-adapted to the South and Southwest of Brazil. It is
commonly used in traditional medicine to treat pain, fever, inﬂammation, asthma, hepatitis, headache,
gastric ulcer, cuts, skin sores and other ailments. The oral antinociceptive effects of standardized 70:30
(v/v) ethanol:water spray dried extract of A. moluccana leaf, as well as its ﬂavonoids 2*-O-rhamno-
sylswertisin (I) and swertisin (II), have previously been reported.
Aim: The aim of this study was to develop a stable and effective semisolid herbal medicine for topical
use in the treatment of pain, inﬂammation and wound healing, containing 0.5 and 1.0% of standardized
dried extract of A. moluccana.
Materials and methods: The chemical markers I and II were assayed by HPLC-UV analysis after
extraction by matrix solid dispersion phase (MSDP) followed analytical validation as ICH Guidelines.
The semisolid preparations of Hostacerin CGs vehicle containing 0.5 and 1.0% of dried extract of
A. moluccana were submitted to stability studies (180 day of accelerated and long-term studies). The
phytomedicine semisolid was analysed in croton oil-induced ear oedema model in mice, in the healing
process, using the excisional wound model in rats, and to prevent mechanical sensitization following
plantar incision in rats in the postoperative model of pain.
Results: The MSDP method showed average recovery of 101.6 and 105.7% for I and II, respectively, with
good precision (RSDo2.0%) and selectivity, without interference of the excipients. The formulations
were approved in the stability studies, maintaining conformity after 180 day of accelerated and long-
term studies, with variationo10% in the analytical parameters. The phytomedicine reduced the ear
oedema in 37.675.7% and 64.876.2%, for 0.5 and 1.0% of dried extract, respectively. The formulation
also accelerated the healing process by up to 50.874.1% and 46.074.0% at 0.5 and 1.0% of extract,
respectively, and both amounts were capable of preventing the development of mechanical sensitiza-
tion following plantar incision in rats.
Conclusions: The MSDP followed by HPLC-UV analytical method was appropriate for the quality control
of the topical phytomedicine based on A. moluccana. The formulation developed at 0.5 and 1.0%
of A. moluccana dried extract proved to be effective as an analgesic, anti-inﬂammatory and wound
healing in the pre-clinical studies, which is in agreement with the ethnopharmacological data.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Leaves of Aleurites moluccana, popularly known as ‘‘Nogueira
da India’’, are used for the treatment of pain and other ailments.
It is commonly known as Kukui (‘‘Light’’) in Hawai’i, candlenut inx: þ55 47 3341 7932.
lin).
der the Elsevier OA license.the USA, tuitui in the Cook Islands and Tonga, lama in Samoa,
ti’a’iri in Tahiti, ‘ama in Marquesas, tutu’i in the Austral Islands,
shi li in China, lauci in Fiji and kurup in Papua New Guinea
(Leonard, 2012). The antinociceptive effect of A. moluccana was
previously demonstrated by Meyre-Silva et al. (1998, 1999) and
mechanical anti-hypersensitivity of the orally dosed standardized
spray dried extract of the plant was recently reported, with 3% of
the chemical marker, the ﬂavonoid 2*-O-rhamnosylswertisin
(Quint~ao et al., 2011). At least in part, the antinociceptive effect
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due to its activity on the peripheral and central pathways of pain
(Quint~ao et al., 2012). Additionally, the sap which wells up at the
stem attachment just after harvesting young kukui fruits is
traditionally used by Hawaiians to treat cuts and skin sores
(Elevitch and Manner, 2006). Malayans apply boiled leaves on
the temples to relieve headache and on the groin to treate
gonorrhoea. Furthermore, Philippinos use oiled leaves to treat
rheumatism (Duke, 1991). Previous studies with extracts and
fractions from leaves and bark of. A. moluccana have shown
biological effects, such as antiviral properties of dichloromethane
fraction (Locher et al., 1996), and antibacterial effects against
Staphylococcus aureus and Pseudomonas aeruginosa (Locher et al.,
1995). The methanol extract from the leaves of A. moluccana also
presented hypolipidemic effects in rats (Pedrosa et al., 2002). It is
important to mention that this plant has been the subject of
extensive investigation by our group, producing a patent aimed at
the development of an analgesic and anti-inﬂammatory phyto-
medicine product (Cechinel et al., 2007). Moreover, to the best of
our knowledge, the topical effects of the referred extract in pain,
inﬂammation and wound healing have not yet been explored in
the literature. The standardization of phytomedicines is impor-
tant for safety and efﬁcacy reasons, due to the geographical and
seasonal variation of the concentration of active compounds in
the plant material. Also, the concentration of compound markers
in the raw material is essential for adjusting the composition of
the ﬁnal product. However, the extraction of active components
from a semisolid formulation usually presents difﬁculties due to
the interference of vehicle components in the analytical methods.
Therefore, the analytical methods previously applied and vali-
dated for the spray dried extract of A. moluccana leaves (Cesca
et al., 2012) must to be adapted to the ﬁnal formulation, in order
to achieve a reasonable recovery of markers I and II from the
semisolid formulations. Matrix solid-phase dispersion (MSPD) has
been shown to be a good alternative to liquid–liquid extraction
due to its simplicity and robustness. It allows complete fractiona-
tion of the sample matrix components and has the ability to
selectively isolate a single compound or several classes of com-
pounds from the sample. MSPD involves direct mechanical
blending of a sample with a SPE sorbent (mainly octadecyl-
modiﬁed silica). In this process, the sorbent acts both as an
abrasive material, disrupting the sample architecture, and as a
‘bound’ solvent that assists in accomplishing sample disruption
(Dawidowicz and Rado, 2010).
The present work concerns the production of a stable topical
semisolid containing standardized spray dried extract of
A. moluccana, the validation of MSPD application for qualitative
and quantitative analysis of the phytopharmaceutical product,
and the evaluation of the new topical phytomedicine in inﬂam-
matory, postoperative pain and wound healing in animal models.2. Material and methods
2.1. Reagents and samples
Methanol and acetonitrile (LC grade) was obtained from J.T.
Baker (Phillipsburg, New Jersey, USA). Water was puriﬁed using
Easy Pure equipment (Waltham, Massachusetts, USA). Silica gel
(0.063–0.2 mesh, Merck), methylparaben and propylparaben
were obtained from Vetec (Duque de Caxias, Rio de Janeiro,
Brazil). Hostacerin CGs (batch BRAC161037), EDTA and butylated
hydroxytoluene were purchased from PharmaSpecial (Santana de
Parnaı´ba. S~ao Paulo, Brazil). Polymols (triglycerides of caprylic
and capric acid) was purchased from All Chemistry (S~ao Paulo,
Brazil). Croton oil was purchased from Sigma Aldrich (St Louis,MO, U.S.A.). Ketamine and xylazine were purchased from Anase-
dans (Miramar, FL, USA) and Dexamethasone from Galena
(Campinas, SP, Brazil). The chemical markers swertisin and 2*-
O-rhamnosylswertisin were isolated from A. moluccana leaves
with HPLC purity of495% (Quint~ao et al., 2011) by our research
group. All the other solvents and reagents were analytical grade,
purchased from national industry and commercially available.
A voucher specimen of A. moluccana, collected in July 2007 in
Tijucas (State of Santa Catarina, Brazil) and identiﬁed by Prof. Dr.
Ademir Reis (Department of Botany/Santa Catarina Federal Uni-
versity-UFSC, Floriano´polis, Brazil), was deposited at the Barbosa
Rodrigues Herbarium (Itajaı´, Brazil) under number VC Filho 001.
The dried extracts composed by 1:10 dried leaves:solvent
(ethanol 70% v/v), submitted to static maceration for 5 day at
room temperature, were prepared at Centroﬂora (Botucatu-SP,
Brazil) on a pilot scale (5 kg) composed of 25% (w/w total solids of
concentrate extract) of colloidal silicon dioxide as describe in
Quint~ao et al. (2011). This dried extract was standardized to
3.0 and 0.4% of I and II, respectively (Cesca et al., 2012).
2.2. Topical semisolid preparations
Semisolid formulations were prepared containing 0.5% and 1%
of A. moluccana standardized dried extract. The extract was
assayed by the HPLC methodology, previously validated by
Cesca et al. (2012). The dried extract was levigated with propy-
lene glycol (5%) before being incorporated into the formulations.
The anionic vehicle Hostacerin CGs (12%), the Polymols (3%), the
preservatives methyl and propylparaben (0.1% of each), the
butylated hydroxytoluene (0.01%) and EDTA (0.1%) were prepared
in single phase without heating. The formulations were packed in
aluminium tubes, with seal and polypropylene cover.
2.3. Instrumentation and chromatographic conditions
A Shimadzu LC-10AD LC system (Shimadzu, Tokyo, Japan) was
used, consisting of a binary pump and a Shimadzu SPD-M10A
photo diode array detector. The samples were monitored at
338 nm and 254 nm. A SIL-10 A auto-sampler and software Class
VP (version 5.33) were used. The injections (20 ml) were carried
out on a C8 X-Bridge 1504.6 mm (5 mm) (Waters, Tauton,
Massachusetts, USA) and conditioned in a Shimadzu CTO-10 A
column oven, equilibrated at 30 1C). The mobile phase consisted
of a gradient A (acidiﬁed water pH 3.5 with acetic acid) and B
(acetonitrile) of 90:10 (A:B) (0 min) to 75:25 (20 min), to 90:10
(30 min), maintaining this composition for 40 min at a ﬂow rate
of 0.5 ml/min (Cesca et al., 2012). All solvents were degassed in an
ultrasonic bath (Unique, S~ao Paulo, Brazil) and all solutions were
ﬁltered through 0.45 mm Millipore Millex PTFE membrane (Maid-
stone, Kent, UK) before injection.
This methodology, previously validated for spray dried extract
from A. moluccana leaves, proved to be linear over a range of
5.89–117.8 and 1.38–27.68 mg/ml for I and II, respectively, accu-
rate (recovery for I and II of 100.3 and 102.8%, respectively), and
precise, with RSD%o1.0% (intra-day) and o3.5% (inter-days) for
area, and less than 0.5% for retention time (Cesca et al., 2012).
2.4. Matrix solid phase dispersion (MSDP) extraction method
The semisolid (2.5 g of placebo or phytomedicine) was mixed
with 10 g of silica (0.063–0.2 mesh) and triturated in a mortar.
This mixture was packed in a 60 ml polypropylene syringe over a
cotton portion previously placed in the bottom of the syringe.
This system was eluted with a single addition of 100 ml of
methanol:dichloromethane 65:35 (v/v). Each experiment was
carried out in triplicate. The elution solvent was evaporated at
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of the extract of A. moluccana previously incorporated into
semisolid formulation, was dissolved in methanol portions and
transferred to a 10 ml volumetric ﬂask, and the volume was made
up with methanol. This solution was ﬁltered and injected in
triplicate into the LC system. The major markers, I and II, were
quantiﬁed comparing the corresponding area with those mea-
sured in the reference solution for calculation of recovery. A blank
was performed using the semisolid components without the dried
extract, to analyze the inﬂuence of the matrix on the recovery of
the markers.
The reference solutions were prepared with the same quantity as
the previous standard (Cesca et al., 2012) dried extract contained in
the aliquot of semisolid used in the extraction process above. The
corresponding quantity of dried extract was dissolved in a 10 ml
volumetric ﬂask with methanol. After 15 min of ultrasound, the
volume was made up to the mark with methanol, ﬁltered and
injected as described for the samples. The reference solution was
freshly prepared each day, and used to analyse the system suitability
of the chromatographic system, by injection of six replicates and
analysis of the retention time, resolution and RSD% of the corre-
sponding marker areas.
2.5. Analytical validation
The extraction method by MSDP was submitted to an analy-
tical validation process following the ICH guideline (2005), using
the semisolid, with 1% and 0.5% of dried extract of A. moluccana.
The selectivity was assessed by PDA detector analysing the purity
of the major peaks and the chromatographic proﬁle at 254 and
338 nm, with the aim of detecting possible interference of the
semisolid components in the marker assay.
The accuracy of the method was evaluated using the semisolid
with 1% of dried extract of A. moluccana, due to the higher
marker concentration, and performing a recovery experiment.
An increased quantity of standardized dried extract (5, 10 and
15 mg) was added to 2.5 g of the semisolid in triplicate. The
sample was homogenised and submitted to the extraction process
described above. The recovery of the markers was calculated in
relation to the freshly prepared reference solution.
The precision of the method was evaluated by repeating the
extraction method as described in Section 2.4, with the semisolid
formulation at 0.5% and 1.0% of dried extract of A. moluccana, in
sextuplicate, on the same day and by the same analyst. These
studies were repeated on two additional days. The average
marker recovery and RSD% were calculated.
2.6. Stability study
The semisolid formulations with 0.5% and 1.0% of A. moluccana
dried extract and the blank (placebo) were submitted to a
stability study by storage at room temperature (2572 1C) and
accelerated conditions in an oven (4072 1C) for 6 months. The
samples were analysed in relation to appearance, pH, homogene-
ity and viscosity, at zero time and after 15, 30, 60, 90 and 180 day.
The markers (I and II) were assayed by HPLC at zero time and
after 90 and 180 day, after clean up the formulations by MSDP.
2.7. Pharmacological study
2.7.1. Animals
Male Swiss mice (25–30 g) and Wistar rats (180–250 g),
obtained from the Universidade do Vale do Itajaı´ (UNIVALI, Itajaı´,
Brazil), were used in this study. The animals were housed under
conditions of optimum light, temperature and humidity (12 h
light-dark cycle, 2271 1C, 60 to 80% humidity), with food andwater provided ad libitum. All procedures used in the present
study followed the ‘‘Principles of Laboratory Animal Care’’ in NIH
publication No. 85-23, and were approved by the Animal Ethics
Committee of UNIVALI (Protocol numbers 358/2009 UNIVALI).
Every effort was made to minimise animal suffering and reduce
the number of animals used.
2.7.2. Croton oil-induced ear oedema
To evaluate the topical anti-inﬂammatory effect, the semisolid
containing standardized spray dried extract of A. moluccana (0.5%
or 1%), dexamethasone (0.5%) or placebo (Hostacerin CGs, 12%)
was applied topically to the inside of the right ear of the mice,
30 min before the application of 20 ml of croton oil (2.5% diluted
in acetone) on the outside of the right ear. The thickness
of the ears was measured before and 4 h after induction of
inﬂammation. Oedema was expressed as the increase in ear
thickness due to the inﬂammatory challenge. Ear thickness was
measured before and after induction of the inﬂammatory
response, using a micrometer (Mitutoyo Series 293). The micro-
meter was applied near the tip of the ear, slightly distal to the
cartilaginous ridges, and the thickness was recorded in mm
(Calixto et al., 1991).
2.7.3. Excisional wound model
Wistar male rats were weighed and anesthetized with xylazine
(20 mg/kg, i.p.) and ketamine (100 mg/kg, i.p.). The animals were
then placed in the prone position and underwent manual trichot-
omy and antisepsis with 0.1% iodine alcohol along the dorsal
midline of the cervical region. The incision area was marked using
a surgical pen and an acetate template (225 mm2). To remove the
skin, subcutaneous tissue, fascia, and ﬂeshy panniculus, a scalpel
and straight scissors and Adson forceps were used (Cross et al.,
1995). After the incision, the layout of each wound was designed,
and approximately 0.7 g of semisolid containing spray dried
extract of A. moluccana (0.5% or 1%), Cicatrenes (neomycin
sulphate and bacitracin zinc), a semisolid commonly used in the
clinic to treat wound healing, or placebo (Hostacerin CGs, 12%)
were applied. The groups of animals received the semisolids once
a day for up to 15 day and the layout of each wound was
performed on days 1, 2, 4, 6, 8, 11 and 15, before the ﬁrst daily
treatment, until the wounds had healed completely.
The layout of each wound was calculated in triplicate and the
arithmetic media for each evaluation was calculated. The wound
areas (cm2) were calculated with Scion Image software (Scion
Corps). The healing percentages of the treated groups were
calculated based on the area under curve (AUC).
2.7.4. Postoperative model of pain
Paw incision was performed as described by Brennan et al.
(1996). In brief, Wistar male rats were anesthetized with xylazine
(20 mg/kg, i.p.) and ketamine (100 mg/kg, i.p.), and after sterile
preparation with 70% ethanol, a 1-cm-long incision was made in
the plantar region of the left hind paw, starting 0.5 cm from the
edge of the heel toward the toe. The plantar muscle was elevated
and incised longitudinally. The wound was closed with two
mattress 5.0 silk sutures. To evaluate the mechanical noci-
ception, rats were individually placed in clear Plexiglass boxes
(181818 cm) on raised wire mesh platforms to allow access
to the ventral surface of the hindpaws. The frequency of with-
drawal response was measured following 10 applications of a von
Frey hair (VFH, Stoelting, Chicago, USA). Pilot studies carried out
in our laboratory have indicated that the 8.0 g VFH produces a
mean withdrawal frequency of about 15%, which was considered
an adequate value for the measurement of mechanical nocicep-
tion. Therefore, only the 8.0 g VFH was used in these experiments.
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(0.5% or 1.0%) or placebo (Hostacerin CGs, 12%) was applied twice
a day for 8 uninterrupted days. The evaluation of mechanicalFig. 1. Chromatograms of: (A) dried extract A. moluccana at 338 nnm; (B) semisolid
(C) semisolid formulation of 1% dried extract of A. moluccana at 254 nm submitted tothresholds was carried out 6 h after the ﬁrst daily application. All
the animal-groups were submitted to previous evaluation to
determine the basal mechanical threshold, and re-evaluated afterformulation of 1% dried extract of A. moluccana at 338 nm submitted to MSDP;
MSDP; D) placebo of semisolid formulation at 254 nm submitted to MSDP.
Table 1
Recovery of markers after spiking the semisolid formulation with 1% of dried
extract of A. moluccana submitted to MSDP followed by HPLC assay.
Amount of reference
material (mg) added to
sample
2*-O-rhamnosylswertisin (I)
recovery (average and RSD%)
swertisin (II)
recovery (average
and RSD%)
5 104.3 (1.7) 102.0 (1.7)
10 101.3 (3.5) 102.6 (3.1)
15 104.9 (3.0) 112.4 (3.2)
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control.
2.7.5. Statistical analysis
The results are presented as the mean7S.E.M. of 5 to 7 ani-
mals. The ID50 values were determined by the least squares
method. The percentages of inhibition are reported as the
mean7S.E.M. of inhibitions obtained for each individual experi-
ment. For the wound healing method, the values for percentage of
inhibition were based on the AUC (area under curve). Statistical
comparisons of the data were performed by one-way analysis of
variance (ANOVA), followed by Dunnett’ test, or by a two-way
ANOVA, followed by Bonferroni’s test. P-values of less than 0.05
(Po0.05 or less) were considered signiﬁcant.3. Results and discussion
Generally, to determine the amount of an active component or
a marker compound present in a crude extract or its derivative
preparations, the use of a chromatographic technique such as
HPLC and a reference material is required. For the analysis of
A. moluccana preparations, the standardized dried extract was
selected as reference material with known assay of the major
markers containing 3.0 and 0.4% of I and II, respectively (Cesca
et al., 2012). This reference material was used to validate the
extraction process (by MSDP) of semisolid formulations contain-
ing 0.5% and 1.0% of standardized dried extract, using the
commercially available anionic vehicle Hostacerin CGs.
3.1. MSDP analytical validation
After extraction of semisolid formulation containing 1.0% of
standardized A. moluccana dried extract by MSDP (Fig. 1b) a
similar chromatographic proﬁle was observed at 338 nm, when
compared to the dried extract (Fig. 1a), applying the previously
validated HPLC method described by Cesca et al. (2012) to this
latter sample, with acceptable resolution between the major
markers (I and II). However, an expressive peak was observed
at 254 nm, eluted at 31 min (Fig. 1c), which was absent in the
dried extract sample at this wavelength (data not shown). It was
attributed to the semisolid components, as shown for the placebo
(Fig. 1d) at the same wavelength, absent at 338 nm (Fig. 1b). The
same result was observed with 0.5% dried extract semisolid
formulation (data not shown). Thus, the selectivity of the method
was demonstrated by the resolution of the interfering compo-
nents of the matrix semisolid formulation in relation to the
markers of A. moluccana extract, which eluted early in the
chromatogram, with no co-elution components of the matrix
semisolid formulation.
The advantages of MSDP include the absence of general
drawbacks associated with liquid–liquid extraction, such as the
use of large amounts of solvent, the occurrence of troublesome
emulsions, and its slowness. MSPD can be carried out simulta-
neously with sample homogenization, extraction and clean-up
(Barker, 2000). MSPD has been used to perform the extraction of a
variety of matrices for a number of compounds, e.g.,: caffeine in
green tea leaves (Dawidowicz and Wianowska, 2005), rutin in
Sambucus nigra L. (Dawidowicz and Wianowska, 2009), polybro-
minated diphenyl ethers and polychlorinated biphenyls in biota
samples (Martinez et al., 2005) phenolic compounds in fruit-
green tea (Karasova and Lehotay, 2004), pesticides in fruits
(Barker, 2000; Blasco et al., 2002; Fernandez et al., 2000; Soler
et al., 2004; Suli et al., 2007; Wang et al., 2007), essential oil
components in herbs (Dawidowicz and Rado, 2010), and umckalinin commercial tincture and syrup of Pelargonium sidoides (Franco
and Oliveira, 2010).
The accuracy of the present MSDP developed method for
analysis of A. moluccana based phytomedicines, followed by HPLC
assay, was evaluated by spiking the sample (semisolid formula-
tion with 1% of dried extract) prior to the extraction process, with
3 doses of reference material, within the previous determined
linearity of the HPLC method. The recovery of the markers was
between 90% and 110%, as recommended for the level of analytes
in the sample (Huber, 2001) and shown in Table 1. The average
recovery for the marker I was 101.6% and 105.7% for II, with
greater bias for the less concentrated analyte.
The MSDP application in intra-day analysis showed good
precision with RSD% values of 1.9 and 2.0% for I and II, respec-
tively, in 1% dried extract semisolid formulation and 2.2 and 3.7%
for I and II, respectively, in 0.5% dried extract semisolid formula-
tion. Also, in the inter-day determination the RSD% were 1.7 and
1.1% for I and II, respectively, in 1% dried extract formulation and
3.8 and 3.3% for I and II, respectively, in 0.5% dried extract
formulation. In both case (intra and inter-day assay) the precision
was higher for 1.0% dried extract formulations, compared with
the 0.5% concentration.
Thus the MSDP extraction method developed proved to be
selective, accurate and precise for the selected markers assayed in
the semisolid Hostacerin CGs formulations, and was applied to
the stability study of the 0.5 and 1.0% dried extract formulations.
3.2. Stability study
The physical characteristics (colour, odour, homogeneity,
clarity and consistency) of semisolid formulations were main-
tained during all the storage conditions. The initial pH of 5.6–6.0
did not show signiﬁcant variation during the study. The initial
apparent viscosity of 500 and 1.200 mPa.s (at 80/s, 25 1C) for
0.5% and 1.0% of dried extract semisolid formulation, respectively,
showed an increase only for the 0.5% dried extract semisolid
formulation after 180 day of storage, in both conditions (room
temperature and 40 1C).
In relation to the marker assay, for the 1.0% dried extract
semisolid formulation, a decreaseo5% was observed at room
temperature ando10% at 40 1C, after 180 day, showing a high
stability of this formulation. On the other hand, the 0.5% dried
extract semisolid formulation showed a variation 410% in both
storage conditions, after the same period. These results suggest
adequate stability of 1.0% dried extract semisolid formulation,
and greater liability of the major ﬂavonoids of the dried extract in
the less concentrated semisolid formulation.
3.3. Pharmacological studies
Fig. 2 demonstrates that the semisolids containing 0.5% or 1.0%
A. moluccana dried extract were capable of signiﬁcantly reducing
ear oedema induced by croton oil when compared with placebo
group (Hostacerin CGs, 12%), with inhibition of 37.675.7% and
64.876.2%, respectively. The results obtained with dexamethasone
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is a viscous liquid obtained from Croton tiglium (Euforbiaceae)
seeds. The croton oil-induced ear oedema model is mainly used to
investigate topical anti-inﬂammatory activity (Tonelli et al., 1965).
The inﬂammatory response induced by topical application of
croton produces oedema (which peaks 6 h after the application),
cell inﬁltration and proliferation, production of arachidonic acid
metabolites (prostanoids and leukotriene), cytokines and other
pro-inﬂammatory mediators (Patrick et al., 1987). The anti-inﬂam-
matory effect of topical treatment with A. moluccana is probably
due to the presence of ﬂavonoids (Tall and Raja, 2004; Meotti et al.,
2007; Filho et al., 2008; Lapa et al., 2009).
With the aim of evaluating the topical healing activity of
A. moluccana dried extract, rats submitted to the wound healing
model were treated daily with semisolid formulations. The results,
presented in Fig. 3 (A and B), show that the topical application of
semisolids Hostacerin CGs containing A. moluccana dried extract
(0.5% and 1.0%) was able to accelerate the healing process by up to
50.874.1% and 46.074.0%, respectively, based on area underFig. 2. Effects of semisolids containing A. moluccana dried extract (0.5% to 1.0%),
dexamethasone (0.5%) or placebo (Hostacerin CGs) on ear oedema induced by
croton oil (2.5%) in mice. Each group represents the mean of 5 to 7 animals, and
the vertical lines indicate the SEM. Signiﬁcantly different from control values: **
po0.01 (one-way ANOVA followed by Dunnett’s post hoc test).
Fig. 3. (A and B) Effects of semisolids containing A. moluccana dried extract (0.5% to 1.0
represents the mean of 5 to 7 animals, and the vertical lines indicate the SEM. Signiﬁcan
post hoc test).curve (AUC) data. Based on these results, we suggest that the
0.5% of dried extract in the semisolid probably achieved the
maximum activity in this protocol once it was administered on
the wound, without a skin barrier. It is important to note that the
rats treated with Cicatrenes, the commercial semisolid commonly
used for wound healing, did not present any difference when
compared with the placebo group. Locher et al. (1995) demon-
strated the antimicrobial activity of A. moluccana extract against
Staphylococcus aureus and Pseudomonas aeruginosa. This activity,
together with the anti-inﬂammatory effects presented above, may
represent primordial factors for the wound contraction and healing
process acceleration evidenced in this study. Furthermore, Said
and co-authors (Said et al., 2007,, 2009) recently demonstrated
that A. moluccana essential oil was capable of conferring ocular
cytoprotection, with corneal epithelium regeneration and reduc-
tion of inﬂammatory cell inﬁltration.
Finally, the antinociceptive activity of topical application of
A. moluccanawas investigated using the postoperative pain model
in rats. This pain model is characterized as acute pain that
develops while the patient is at rest (Brennan et al., 1996).
Currently, acute postoperative pain remains a major clinical
problem, and it is known that effective treatment can facilitate
patient recovery (Kehlet and Holte, 2001; Brennan, 2011). The
identiﬁcation of pre-operative intervention methods requires an
understanding of the molecular mechanisms involved (Pogatzki
and Raja, 2003). Studies performed by Weber et al., 2005 in rats
demonstrated that primary mechanical sensitization persisted for
up to 6 day after surgery, whereas secondary mechanical sensi-
tization was maintained for up to 1 day after surgery (Zahn and
Brennan, 1999). It was demonstrated that after plantar incision in
rats, there is an increase of Ab (Ha¨ma¨la¨inen et al., 2002) and/or
Ad (Pogatzki et al., 2002) ﬁbers, otherwise the responsiveness of
the C ﬁbers remained unchanged. Considering that the existing
drugs for the treatment of post-operative pain present major side
effects, such as nausea, vomiting, ileus, respiratory depression,
and sedation (Dahl and Kehlet, 2006), several pharmaceutical
companies have sought to develop new effective and safe therapy
(topical or systemic) for the prevention and treatment of post-
operative pain. We have previously demonstrated the antinoci-
ceptive activity of A. moluccana spray dried extract and the
ﬂavonoids swertisin and 2*-O-rhamnosylswertisin, when admi-
nistered orally, in different models of mechanical hypersensitivity
in mice (Quint~ao et al., 2011). Recently, Quint~ao et al. (2012)
suggest that the compounds present in the A. moluccana dried
extract, mainly 2*-O-rhamnosylswertisin, showed antinociceptive
effect by interacting with (1) opioid system enhancing the%), Cicatrenes or placebo (Hostacerin CGs) on wound healing in rats. Each group
tly different from control values: * po0.05 (one-way ANOVA followed by Dunnett’s
Fig. 4. Effects of semisolids containing A. moluccana dried extract (0.5% to 1.0%) or
placebo (Hostacerin CGs) on the post-operative pain induced by plantar incision
in rats. Each group represents the mean of 5 to 7 animals, and the vertical lines
indicate the SEM. Signiﬁcantly different from control values: *** po0.001;
signiﬁcantly different from basal naive group mechanical threshold: # po0.001
(Two-way ANOVA followed by Bonferroni’s post hoc test).
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system reducing the central sensitization resulted from glutamate
activity; and (3) the inﬂammatory components such as neutrophil
migration and cytokine release (IL-1b).
In this study, the repeated topical application (2day, for up
to 8 consecutive days) of semisolids containing A. moluccana dried
extract (0.5% or 1.0%), prevented the development of mechanical
sensitization after plantar incision in rats, as observed in Fig. 4.
The absence of an efﬁcient commercial topical drug for treating
postoperative pain emphasizes the importance of the results
obtained, which may accelerate the patient’s recovery, poten-
tially reducing adverse effects and increasing the adherence to
treatment.4. Conclusions
The semisolid formulations containing dried extract of
A. moluccana showed important topical pharmacological results in
inﬂammation, pain and healing process, in agreement with ethno-
pharmacological data (Duke, 1991). The polar components of dried
extract were successful extracted by MSDP followed HPLC-UV. This
method was validated and showed adequate selectivity, with
average recovery of 101.6% for 2*-O-rhamnosylswertisin (I) and
105.7% for swertisin (II), and with appropriate intra-day and inter-
day precision (RSD below 2.0%). The marker content for the
semisolids was 98.5% and 99.2% for 2*-O-rhamnosylswertisin and
103.2% and 112.5% for swertisin, when evaluated in 0.5% and 1.0% of
dried extract of A. moluccana semisolid formulations, respectively.
The novelty of the present work is the development of a stable
semisolid phytomedicine for topical use, based on ethnopharmaco-
logical data; the validation of an analytical method for quality
control of the phytomedicine and the demonstration of its topical
biological activities in the treatment of the post-operative pain,
would healing and inﬂammation, have not yet been described.Acknowledgments
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LC: Liquid chromatography;
HPLC: High pressure liquid chromatography;
EDTA: Ethylenediaminetetraacetic acid;
RSD: Relative standard deviation;
MSPD: Matrix solid phase dispersion;
ICH: International conference on harmonisation;
PDA: Photodiode array;
UNIVALI: University of vale of Itajaı´;
AUC: Area under curve;
ANOVA: Analysis of variance;
pH: Potential of hydrogen;
UV: Ultraviolet.
